ARCHIVES

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 34 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

UICC Announces Four Grant award Programs

July 14, 1978

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

ASCO Updates Guideline On Antiemetics

June 30, 2006